Catalyst Wire Dossier Catalyst Wire Dossier

Polyethylene-Glycol-Conjugated Interleukin 2

polyethylene glycol-conjugated interleukin-2 · Icahn School of Medicine at Mount Sinai
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Polyethylene-Glycol-Conjugated Interleukin 2, covering 2015-03-25 to 2015-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency [NA]

See pricing